You can buy or sell DARE and other stocks, options, ETFs, and crypto commission-free!
Daré Bioscience, Inc. operates as a healthcare company. It engages in the development and commercialization of pharmaceutical products in women's reproductive health. Read More Its products inclide Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert, and Roger L. Hawley in 2015 and is headquartered in La Jolla, CA.
La Jolla, California
52 Week High
52 Week Low
Dare Bioscience stock rockets to pace all gainers after positive findings from VVA treatment study
Shares of Daré Bioscience Inc. DARE, +139.13% rocketed 129% on very heavy volume toward a 13-month high in afternoon trade Monday, after the biopharmaceutical company announced positive findings for the use of its DARE-VVA1 product candidate in treating vulvar and vaginal atrophy (VVA). The stock was the biggest percentage gainer listed on major U.S. exchanges, even though it pared earlier gains of as much as 253%. Volume swelled to 37.8 million shares, compared with the full-day average of about 82,500 sha...
Dare Bioscience Skyrockets On Positive Data For Vaginal Dryness Drug (NASDAQ:DARE)
Dare Bioscience Inc (NASDAQ: DARE), a nanocap biotech company focused on developing therapies for women's health, is enjoying a moment in the spotlight thanks to positive results for its vaginally administered tamoxifen.